Logista, ES0105027009

Logista stock gets a lift from its vaccine logistics campaign

Published on 10/07/2026 at 13:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Logista Pharma planned 6 million influenza vaccine doses for 3,200 supply points on October 6, 2026. Third-quarter net income rose 17 percent to EUR 74.0 million.

Logista, ES0105027009, Illustration mit AI erstellt.
Logista, ES0105027009, Illustration mit AI erstellt.

Logista stock was trading at EUR 34.66 on BME on October 7, 2026 at 1:40 p.m. CEST, while the logistics group expanded its pharmaceutical role with a vaccine campaign covering 6 million influenza doses. The company also reported third-quarter 2026 net income of EUR 74.0 million, up 17 percent from the comparable period.

Pharma operation scales up

According to Logista on October 6, 2026, Logista Pharma is coordinating deliveries to more than 3,200 supply points across Spain. The campaign also includes 840,320 COVID-19 vaccine doses and 206,720 vials for about 900 delivery points in the Community of Madrid.

The operating intensity is visible in the transport figures. Logista Pharma increases its daily vehicle deployment from 16 to more than 40 during peak periods, representing an increase of more than 150 percent, while the Madrid service has been extended through September 2027, according to Logista.

Third-quarter profit improves

Simply Wall St reported that third-quarter 2026 revenue reached EUR 3.57 billion, up 1.7 percent from the third quarter of 2025. Net income increased from EUR 63.2 million to EUR 74.0 million, lifting the profit margin from 1.8 percent to 2.1 percent.

That combination matters because Logista operates with a large distribution base and relatively narrow margins. The latest figures show that a modest revenue increase was accompanied by a larger profit gain, giving pharmaceutical and other higher-value services greater importance in the earnings mix.

Consensus stays below market price

According to Marketscreener, the consensus rating was Hold among 11 analysts, with an average target price of EUR 32.54 versus a reference price of EUR 35.34 in its September 21, 2026 overview. The average target was 7.93 percent below that reference price, making valuation and the durability of profit growth the main counterweights to the pharmaceutical expansion.

Logista stock holds above EUR 34

Logista stock was last at EUR 34.66 on BME on October 7, 2026, up 0.70 percent, with 37,728 shares traded. The session range was EUR 34.38 to EUR 34.74, while the 52-week range stood at EUR 28.16 to EUR 37.76 and market capitalization was EUR 4.6 billion.

Logista stock facts

  • Company: Logista Integral, S.A.
  • ISIN: ES0105027009
  • Ticker: LOG
  • Trading venue: BME
  • Price (as of October 7, 2026, 1:40 p.m. CEST): EUR 34.66
  • Market capitalization: EUR 4.6 billion (as of October 7, 2026)
  • 52-week range: EUR 28.16-EUR 37.76 (as of October 7, 2026)
  • Sector / Industry: Industrials / Integrated Freight and Logistics
  • Index membership: IBEX 35

Upcoming dates for Logista stock

  • November 6, 2026: fiscal-year results

More news and analyses on Logista stock

Disclaimer...

en | ES0105027009 | LOGISTA | boerse | 70255418 | bgmi